BackSingular Genomics Systems Overview

Singular Genomics Systems Research & Development

Get informed when a big investor buys or sells

+ Follow

Quarterly R&D Expenses

$9.57M
14.72% YoY

As of Sep 30, 2024

Annual R&D Expenses (TTM)

$43.48M
7.16% YoY

Trailing 12 months ending Sep 30, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Singular Genomics Systems (OMIC) FAQ

Stockcircle tracks research & development for Singular Genomics Systems (OMIC), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Research & Development page is built for Singular Genomics Systems's historical R&D spending trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use R&D spending as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main OMIC overview so you can move from this figure to the surrounding analysis quickly.